Thalidomide therapy of established collagen-induced arthritis (CIA) not accompanied by an evident Th2 shift

Clinical and Experimental Immunology

Volumn 108, Issue 3, 1997, Pages 428-431

  Hauschild, A ^a   Kroeger, H ^a   Mitchison, N A ^a   Ugrinovic, S ^a   Zwingenberger, K ^b  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b GRÜNENTHAL GMBH   (Germany)

Author keywords

arthritis; collagen; Th1 Th2; thalidomide

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; THALIDOMIDE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 0030904683     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.3781274.x     Document Type: Article

References (22)

1. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91:8562-6.
2. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397-440.
3. Burmester GR, Daser A, Kamradt T et al. Immunology of reactive arthritides. Annu Rev Immunol 1995; 13:229-50.
4. Yin Z, Braun J, Neure L et al. T-cell cytokine pattern in the joint of Lyme arthritis patients and its regulation by cytokines and anticytokines. Arthritis Rheum 1997; 40:69-79.
5. Zwingenberger K, Wnendt S. Immunomodulation by thalidomide. Systematic review of the literature and of observations. J Inflamm 1996; 46:177-211.
6. Gutierrez RO, Starusta BP, Gutierrez MO. Treatment of refractory rheumatoid arthritis - the thalidomide experience. J Rheumatol 1989; 16:158-63.
7. McHugh SM, Rifkin IR, Deighton J et al. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995; 99:160-7.
8. Sampaio EP, Kaplan G, Miranda A et al. The influence of thalidomide on the clinical and immunologie manifestation of erythema nodosum leprosum. J Infect Dis 1993; 168:408-14.
9. Hanke JH, Gardner JP, Dow RL et al. Discovery of a novel, potent, and Src family selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 1996; 271:695-701.
10. Wooley PH. Collagen-induced arthritis in the mouse. Methods Enzymol 1988; 162:361-73.
11. Holmdahl R, Andersson M, Goldschmidt TJ et al. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990; 118:193-232.
12. Klareskog L, Olsson T. Autoimmunity to collagen II and myelin basic protein: comparative studies in humans and rodents. Immunol Rev 1990; 118:285-310.
13. Miesel R, Dietrich A, Ulbrich N et al. Assessment of collagen type II induced arthritis in mice by whole blood chemiluminescence. Autoimmunity 1994; 19:153-9.
14. Mitchison NA, Brunner MC. Association of H2Ab with resistance to collagen-induced arthritis in H2-recombinant mouse strains: an allele associated with reduction of several apparently unrelated responses. Immunogenetics 1995; 41:239-45.
15. Mauri C, Williams RO, Walmsley M et al. Relationship between Th1/ Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996; 26:1511-8.
16. Tsutsumi S, Gidoh M. Inefficacy of thalidomide on rat adjuvant-induced arthritis and lack of arthrogenicity of Hansen bacilli. Nippon Rai Gakkai Zasshi 1988; 57:122-8.
17. Hess H, Gately MK, Rude E et al. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Eur J Immunol 1996; 26:187-91.
18. van den Berg W, Joosten LA, Helsen M et al. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol 1994; 95:237-43.
19. Brunner MC, Larsen S, Sette A et al. Altered Th1/Th2 balance associated with the immunosuppressive/protective effect of the H-2Ab allele on the response to allo-HPPD. Eur J Immunol 1995; 25:3285-9.
20. Sampaio EP, Sarno EN, Galilly R et al. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991; 175:699-703.
21. Moreira AL, Sampaio EP, Zmuidzinas A et al. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993; 177:1675-80.
22. Elliott MJ, Maini RN, Feldmann M et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993; 36:1681-90.